Happy to share our latest publication led by co-first authors Jeremy Miles &
@AndreaScotti21
just out in
@CircAHA
We found:
➡️Heterogeneity of mortality risk in patients with LDL-C ≥190mg/dl.
➡️Undertreatment w/ 25% not prescribed statin therapy & 55%
We have an opening for this July 2024 1-year advanced imaging fellowship at
@MonteHeart
. Fellowship includes CT/MRI (about 40 studies per day), advanced echo/structural, PET (including hybrid PET-MR) and SPECT.
Applicants need to have USMLE certification.
If interested, please
Thrilled to celebrate the graduation of our advanced imaging fellows! Proud to witness their journey into esteemed academic roles as cardiac imagers in top healthcare systems. Congrats Jeirym, Ola and Safwan 👏🏻.
@MonteHeart
@MontefioreNYC
#ACCimaging
@aschenonegiugni
Just published from our group. Congrats
@pamelapina_s
&
@danilorenzatti
!
Association of Cardiometabolic and Vascular Atherosclerosis Phenotypes on Non-Contrast Chest CT with Incident Heart Failure in Patients with Severe Hypercholesterolemia.
@virani_md
Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art Review
👏🏻👏🏻👏🏻
👉🏻Early-stage subclinical atherosclerosis can be identified in young individuals, but evidence-based strategies are needed to prevent progression of disease and clinical
New work from our group led by
@pamelapina_s
&
@CFernandezHazim
.
➡️Subclinical atherosclerosis detected on non-contrast, routine chest CT as CAC or TAC-> higher mortality in young patients with LDL-C>190 mg/dL.
➡️9% had CAC & 14%TAC
➡️CAC was associated with increased all cause
🤯🧨Only 29.9% of beneficiaries had their LDL-C measured within 90 days following MI hospital discharge.
Low-Density Lipoprotein Cholesterol Testing Following Myocardial Infarction Hospitalization Among Medicare Beneficiaries | JACC: Advances
Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial
“In this highly diseased, high-risk population, enhanced assessment of atherosclerotic burden using AI-QCT-derived measures of plaque volume and composition modestly improved event
Happy to announce our new cardiometabolic clinic at
@MontefioreNYC
. Multidisciplinary approach. Family clinic for FH. Diabetes + CV disease. Resistant hypertension. Team:Dr Stein (endocrine), Dr Mahgerefteh (pediatrics), Dr Fisher (renal), Dr Vukelic (heart failure) and myself.
Great session 👏🏻👌 on optimizing proven approaches to improve cholesterol management
@virani_md
@ErinMichos
@ProfSNicholls
@rauldsf_santos
👉🏻new digital technologies offer unique opportunities but who covers the cost needs to be defined
👉🏻we have the same issues with low
Navigating Cardiovascular Risk Assessment in Older Patients: Insights From Coronary Artery Calcium Scoring - American College of Cardiology
#ACCimaging
@MichaelJBlaha
Join us at the ACC.24 CV Imaging Section Meeting & Reception.
Really looking forward to meet everyone in person!
📅 Sat, April 6
🕕 6-7:30 p.m. ET
RSVP:
@ACCinTouch
#ACCImaging
#ACCFIT
#ACC24
Check our manuscript just published in
@MayoProceedings
- Empagliflozin and Cardiovascular Outcomes Across Urine Albumin to Creatinine Ratio Categories: A Systematic Review and Meta-analysis.
Congrats
@AbdelazizMD1
!
@MonteHeart
New collaboration paper just came out
@JAMACardio
@DrPJoshi
@MonteHeart
There is significant heterogeneity in lipoprotein(a) levels across the diverse US Hispanic or Latino population.
Join us tomorrow to learn about rapid and intensive GDMT for heart failure from
@gcfmd
with
@MonteHeart
.
Friday, December 1st , 2023
From 12:00 pm EST – 1:00 pm EST
Click On 👉🏻
Thank you
@HTMagazines
for the opportunity to write an editorial on the impact of cardiac CT on coronary atherosclerosis diagnosis & treatment.
@MonteHeart
@Heart_SCCT
Outstanding lecture on rapid and intensive GDMT for heart failure by
@gcfmd
at
@MonteHeart
. Recording here 👉🏻
We need:
💪🏻Overcome therapeutic inertia and biases.
⏰Hospital initiation of quadruple GDMT for those admitted with HF.
❗️Simultaneous/rapid
New editorial with
@totocarbone
and Carl Lavie 👉🏻 Physical activity with or without dietary intervention for the prevention of cardiovascular diseases
@MonteHeart
The importance of nonobstructive plaque characteristics in symptomatic and asymptomatic coronary artery disease
👉🏻 Nonobstructive CAD was the predominant contributor to total atherosclerotic plaque volume in both subclinical and clinically manifested CAD.
👉🏻Nonobstructive
Percutaneous
#TMVR
with the Cephea valve system in - prior surgical edge-to-edge repair - severe MAC electrosurgery and dedicated devices might be beneficial to treat complex anatomies
#JACCINT
#TEER
@AndreaScotti21
@azeemlatib
💡USPSTF released recs for statin therapy for primary prevention last week
💡They require at least 1 ♥️risk factor AND 10-yr ASCVD risk >=10%
💡We examine the impact on the US population vs. 2018 AHA/ ACC/Multi Society Guidelines (1/4)
Great editorial by
@nstonedoc
and Conrad Blum about our Circulation paper. Highly recommend 👉🏻If Action is Delayed, Is Survival Denied? Management of Severe Hypercholesterolemia Is Important and Urgent | Circulation
@AndreaScotti21
@DrMichaelShapir
Deep Learning For Differentiation of Constrictive Pericarditis and Restrictive Cardiomyopathy Using Echocardiography - American College of Cardiology
#ACCimaging
@DocStrom
Whats the latest in lipid-lowering therapies? Great review: Monoclonal Antibodies, Gene Silencing and Gene Editing (CRISPR) Therapies for the Treatment of Hyperlipidemia-The Future Is Here
@melody_hermel
@JamalRanaMD
@virani_md